Published in J Virol on September 20, 2017
Structural and functional features of central nervous system lymphatic vessels. Nature (2015) 8.73
A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature (2000) 6.89
Germinal centers. Annu Rev Immunol (2012) 6.26
B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res (1997) 5.43
Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol (2006) 5.22
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol (2005) 5.10
Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (1995) 4.10
Antibody-mediated clearance of alphavirus infection from neurons. Science (1991) 3.70
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med (2007) 3.45
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity (1995) 2.69
Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol (2006) 2.53
B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol (2006) 2.52
Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol (2003) 2.19
Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol (1999) 2.19
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain (2005) 2.17
Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood (2011) 2.15
Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1973) 2.10
Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol (2006) 2.06
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc (2014) 2.06
IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med (2005) 1.92
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.91
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol (2006) 1.62
The role of antibody in recovery from alphavirus encephalitis. Immunol Rev (1997) 1.60
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood (2005) 1.51
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med (2014) 1.49
Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol (2002) 1.48
Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J Immunol (2009) 1.45
Complement in the brain. Mol Immunol (2011) 1.41
Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection. J Virol (2003) 1.37
Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J Virol (2008) 1.35
The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis (2009) 1.34
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation (2012) 1.29
Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation. J Immunol (2003) 1.26
Herpes simplex encephalitis: A serological follow-up study. Synthesis of herpes simplex virus immunoglobulin M, A, and G antibodies and development of oligoclonal immunoglobulin G in the central nervous system. Acta Neurol Scand (1981) 1.24
CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum (2007) 1.23
The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation (2009) 1.22
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol (2005) 1.22
Determining germinal centre B cell fate. Trends Immunol (2012) 1.20
The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis. Ann Neurol (2005) 1.17
Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J Immunol (2001) 1.16
Antibody prevents virus reactivation within the central nervous system. J Immunol (1999) 1.14
Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis. J Immunol (2002) 1.13
CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur J Immunol (2006) 1.10
CD19 function in central and peripheral B-cell development. Immunol Res (2005) 1.10
Lymphoid chemokines in the CNS. J Neuroimmunol (2010) 1.07
The 1-1-1 fallacy. Immunol Rev (2012) 1.06
Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons. Immunol Res (2010) 1.06
Control of central nervous system viral persistence by neutralizing antibody. J Virol (2003) 1.05
CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. J Virol (2011) 1.05
Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol (2010) 1.03
Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol (1999) 1.02
The B cell response in multiple sclerosis. Neurol Res (2006) 1.00
B cells undergo unique compartmentalized redistribution in multiple sclerosis. J Autoimmun (2011) 0.99
Virus-specific antibody-producing cells in blood and cerebrospinal fluid in acute Japanese encephalitis. J Med Virol (1985) 0.98
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system. Brain Behav Immun (2010) 0.98
Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease. Eur J Clin Invest (2013) 0.97
Progressive rubella virus panencephalitis: synthesis of oligoclonal virus-specific IgG antibodies and homogeneous free light chains in the central nervous system. Acta Neurol Scand (1978) 0.96
Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J Exp Med (1998) 0.96
Expression of complement messenger RNAs and proteins by human oligodendroglial cells. Glia (2003) 0.96
The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch Virol (1991) 0.95
Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J Immunol (2010) 0.95
A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand J Immunol (2007) 0.93
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol (2014) 0.93
Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis. J Virol (2011) 0.93
Virus-specific regulatory T cells ameliorate encephalitis by repressing effector T cell functions from priming to effector stages. PLoS Pathog (2014) 0.88
Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J Immunol (1999) 0.87
Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis. J Virol (2013) 0.87
Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis. J Virol (2012) 0.87
Role of CD19 signal transduction in B cell biology. Immunol Res (2002) 0.86
Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody. J Neuroimmunol (2007) 0.85
In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination. J Gen Virol (2008) 0.85
An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM. Neurology (1999) 0.82
Experimental intracerebral vaccination protects mouse from a neurotropic virus by attracting antibody secreting cells to the CNS. Immunol Lett (2011) 0.81
IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis. J Neuroimmunol (2013) 0.81
Intrathecal humoral responses are inversely associated with the frequency of simian immunodeficiency virus macrophage-tropic variants in the central nervous system. J Virol (2009) 0.80
Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. J Virol (2014) 0.80
Intrathecal humoral immunity to encephalitic RNA viruses. Viruses (2013) 0.80
Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination. Glia (2015) 0.80
Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV. J Neurol (1989) 0.79
Diagnostic significance of intrathecally produced herpes simplex and varizella-zoster virus-specific antibodies in central nervous system infections. Swiss Med Wkly (2004) 0.78
Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation. Immunity (2016) 0.77
Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses. Immunity (2017) 0.76
CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis. Brain Behav Immun (2016) 0.76
Detection of virus specific IgG subclasses in Japanese encephalitis patients. Indian J Med Res (1991) 0.76
Roles of regulatory T cells and IL-10 in virus-induced demyelination. J Neuroimmunol (2017) 0.76
An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation. J Neurosci Methods (2017) 0.75
Activated GL7(+) B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. Brain Behav Immun (2016) 0.75
Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. J Virol (2014) 0.80
Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis. J Virol (2015) 0.75
Neuronal ablation of IFNα/β signaling exacerbates CNS viral dissemination and impairs IFNγ responsiveness in microglia/macrophages. J Virol (2020) 0.75